{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-034563","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.432290+00:00","generated_at":"2026-05-30T02:37:22.091987+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Azenta reports Q4 FY2024 revenue $170M; plans to sell B Medical; appoints Lawrence Lin CFO","bullets":["FY2024 combined Sample Mgmt & Multiomics organic revenue grew 4%; Q4 organic growth 5%.","Full year Adjusted EBITDA margin expanded ~300 bps to 7.5%; FY2025 guidance: 3-5% organic revenue growth and ~300 bps margin expansion.","Board pursuing sale of B Medical Systems segment to simplify portfolio and focus on core businesses.","Lawrence Lin appointed CFO effective after FY2024 10-K filing; Herman Cueto to serve as advisor through Q1 FY2025.","Completed $1.5B share repurchase program, repurchasing 30M shares through September 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-034563","json":"https://secwatch.observer/filing/0001437749-24-034563.json","markdown":"https://secwatch.observer/filing/0001437749-24-034563.md","text":"https://secwatch.observer/filing/0001437749-24-034563.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000143774924034563/0001437749-24-034563-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000143774924034563/azta20240708_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:37:22.091987+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2bab6c5e7a","claim":"Herman Cueto departed as Executive Vice President and Chief Financial Officer at Azenta, Inc..","evidence_excerpt":"Herman Cueto, who is departing from his role at the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924034563/0001437749-24-034563-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departing"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}]},{"claim_id":"8cb8170513","claim":"Lawrence Lin was appointed as Executive Vice President and Chief Financial Officer at Azenta, Inc..","evidence_excerpt":"appointed Lawrence Lin as its Executive Vice President and Chief Financial Officer, effective as of Effective Time","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924034563/0001437749-24-034563-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}